275 related articles for article (PubMed ID: 30471280)
1. Biomechanical changes to Descemet's membrane precede endothelial cell loss in an early-onset murine model of Fuchs endothelial corneal dystrophy.
Leonard BC; Jalilian I; Raghunathan VK; Wang W; Jun AS; Murphy CJ; Thomasy SM
Exp Eye Res; 2019 Mar; 180():18-22. PubMed ID: 30471280
[TBL] [Abstract][Full Text] [Related]
2. L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy.
Meng H; Matthaei M; Ramanan N; Grebe R; Chakravarti S; Speck CL; Kimos M; Vij N; Eberhart CG; Jun AS
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1887-97. PubMed ID: 23422828
[TBL] [Abstract][Full Text] [Related]
3. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis.
Jun AS; Meng H; Ramanan N; Matthaei M; Chakravarti S; Bonshek R; Black GC; Grebe R; Kimos M
Hum Mol Genet; 2012 Jan; 21(2):384-93. PubMed ID: 22002996
[TBL] [Abstract][Full Text] [Related]
4. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene.
Gottsch JD; Zhang C; Sundin OH; Bell WR; Stark WJ; Green WR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4504-11. PubMed ID: 16303941
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation.
Zhang C; Bell WR; Sundin OH; De La Cruz Z; Stark WJ; Green WR; Gottsch JD
Trans Am Ophthalmol Soc; 2006; 104():85-97. PubMed ID: 17471329
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy.
Matthaei M; Meng H; Meeker AK; Eberhart CG; Jun AS
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6718-27. PubMed ID: 22956607
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine increases corneal endothelial cell survival in a mouse model of Fuchs endothelial corneal dystrophy.
Kim EC; Meng H; Jun AS
Exp Eye Res; 2014 Oct; 127():20-5. PubMed ID: 24952277
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs' endothelial corneal dystrophy.
Matthaei M; Hu J; Meng H; Lackner EM; Eberhart CG; Qian J; Hao H; Jun AS
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1931-40. PubMed ID: 23449721
[TBL] [Abstract][Full Text] [Related]
9. Lithium treatment increases endothelial cell survival and autophagy in a mouse model of Fuchs endothelial corneal dystrophy.
Kim EC; Meng H; Jun AS
Br J Ophthalmol; 2013 Aug; 97(8):1068-73. PubMed ID: 23759441
[TBL] [Abstract][Full Text] [Related]
10. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy.
Gottsch JD; Sundin OH; Liu SH; Jun AS; Broman KW; Stark WJ; Vito EC; Narang AK; Thompson JM; Magovern M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1934-9. PubMed ID: 15914606
[TBL] [Abstract][Full Text] [Related]
11. A cellular model for the investigation of Fuchs' endothelial corneal dystrophy.
Kelliher C; Chakravarti S; Vij N; Mazur S; Stahl PJ; Engler C; Matthaei M; Yu SM; Jun AS
Exp Eye Res; 2011 Dec; 93(6):880-8. PubMed ID: 22020132
[TBL] [Abstract][Full Text] [Related]
12.
Moschos MM; Diamantopoulou A; Gouliopoulos N; Droutsas K; Bagli E; Chatzistefanou K; Kitsos G; Kroupis C
In Vivo; 2019; 33(3):963-971. PubMed ID: 31028223
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Matrix and Integrin Expression Profiles in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Model.
Goyer B; Thériault M; Gendron SP; Brunette I; Rochette PJ; Proulx S
Tissue Eng Part A; 2018 Apr; 24(7-8):607-615. PubMed ID: 28726551
[TBL] [Abstract][Full Text] [Related]
15. The pathophysiology of Fuchs' endothelial dystrophy--a review of molecular and cellular insights.
Zhang J; Patel DV
Exp Eye Res; 2015 Jan; 130():97-105. PubMed ID: 25446318
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
[TBL] [Abstract][Full Text] [Related]
17. The soil and the seed: The relationship between Descemet's membrane and the corneal endothelium.
Petrela RB; Patel SP
Exp Eye Res; 2023 Feb; 227():109376. PubMed ID: 36592681
[TBL] [Abstract][Full Text] [Related]
18. The Ultrastructures and Mechanical Properties of the Descement's Membrane in Fuchs Endothelial Corneal Dystrophy.
Xia D; Zhang S; Nielsen E; Ivarsen AR; Liang C; Li Q; Thomsen K; Hjortdal JØ; Dong M
Sci Rep; 2016 Mar; 6():23096. PubMed ID: 26980551
[TBL] [Abstract][Full Text] [Related]
19. Fuchs Endothelial Corneal Dystrophy: A Systematic Immunofluorescence Study of Collagen Type VIII Suggests Heterogeneous Pathophysiology.
Nielsen E; Nielsen K; Ivarsen A; Greenhill NS; Davis PF; Hjortdal J
Cornea; 2016 Jun; 35(6):872-7. PubMed ID: 27078008
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
